CHEPLAPHARM ARZNEIMITTEL Cheplapharm Arzneimittel GmbH is a security (CUSIP 16412EAA5) tracked across SEC portfolio filings. 5 registered fund positions totaling $4.5M via N-PORT as of 2024-08-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Guggenheim Credit Allocation Fund | Guggenheim Credit Allocation Fund | $2.3M | 107.88% |
| Delaware Ivy High Income Opportunities Fund | Ivy High Income Opportunities Fund | $1.4M | 71.80% |
| BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | $418K | 30.23% |
| Delaware Enhanced Global Dividend & Income Fund | Delaware Enhanced Global Dividend & Income Fund | $186K | 28.15% |
| Delaware Investments Dividend & Income Fund, Inc | Delaware Investments Dividend & Income Fund, Inc | $177K | 26.77% |